Clinical Impact of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement.
Santiago GarciaMiho FukuiMarshall W DworakBrynn K OkesonRoss F GarberichGo HashimotoHirotomo SatoJoão L CavalcanteVinayak N BapatJohn LesserVictor ChengMarc C NewellMario GoesslSammy ElmariahSteven M BradleyPaul SorajjaPublished in: Circulation. Cardiovascular interventions (2022)
In a large, real-world cohort of patients receiving TAVR followed by systematic screening with CTA 30-days post-procedure, HALT was found in 12% of patients and independently associated with long-term mortality. Findings of this nonrandomized, observational cohort study require independent validation.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- aortic stenosis
- ejection fraction
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- prognostic factors
- mitral valve
- minimally invasive
- cardiovascular events
- type diabetes
- cardiovascular disease
- left ventricular
- risk factors
- patient reported outcomes
- peritoneal dialysis
- patient reported